SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)

被引：0
|
作者：
Ho, Thai H. [1 ]
Monzon, Federico A. [2 ]
Anh Hoang [1 ]
Tamboli, Pheroze [1 ]
Furge, Kyle [3 ]
Dykema, Karl [3 ]
Petillo, David [3 ]
Teh, Bin Tean [3 ]
Tannir, Nizar [1 ]
Jonasch, Eric [1 ]
Hung, Mien-Chie [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Van Andel Inst, Grand Rapids, MI USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1035
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The histone methyltransferase SETD2 regulates HIV expression and latency
    Bussey-Sutton, Cameron R.
    Ward, Airlie
    Fox, Joshua A.
    Turner, Anne-Marie W.
    Peterson, Jackson J.
    Emery, Ann
    Longoria, Arturo R.
    Gomez-Martinez, Ismael
    Jones, Corbin
    Hepperla, Austin
    Margolis, David M.
    Strahl, Brian D.
    Browne, Edward P.
    PLOS PATHOGENS, 2024, 20 (06)
  • [22] Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling
    Jiang, Chaoying
    He, Chao
    Wu, Zhiqiang
    Li, Fengfeng
    Xiao, Jianru
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 502 (03) : 382 - 388
  • [23] Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC)
    Shaikh, Shafiq
    Zhao, Xia
    Wagner, Ryan T.
    Pan, Xiaoyu
    Hlady, Ryan A.
    Wang, Liguo
    Ho, Thai H.
    Robertson, Keith D.
    EPIGENETICS, 2025, 20 (01)
  • [24] Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma
    Li, Jun
    Kluiver, Joost
    Osinga, Jan
    Westers, Helga
    van Werkhoven, Maaike B.
    Seelen, Marc A.
    Sijmons, Rolf H.
    van den Berg, Anke
    Kok, Klaas
    NEOPLASIA, 2016, 18 (06): : 339 - 346
  • [25] Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma
    Takeda, Kotaro
    Bastacky, Sheldon
    Dhir, Rajiv
    Mohebnasab, Maedeh
    Quiroga-Garza, Gabriela M.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 68
  • [26] Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma
    Rao, Hanyu
    Li, Xiaoxue
    Liu, Min
    Liu, Jing
    Feng, Wenxin
    Tang, Huayuan
    Xu, Jin
    Gao, Wei-Qiang
    Li Li
    CANCER RESEARCH, 2021, 81 (13) : 3554 - 3567
  • [27] PBRM1, SETD2 and BAP1-the trinity of 3p in clear cell renal cell carcinoma
    Walton, Joseph
    Lawson, Keith
    Prinos, Panagiotis
    Finelli, Antonio
    Arrowsmith, Cheryl
    Ailles, Laurie
    NATURE REVIEWS UROLOGY, 2023, 20 (02) : 96 - 115
  • [28] PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
    Joseph Walton
    Keith Lawson
    Panagiotis Prinos
    Antonio Finelli
    Cheryl Arrowsmith
    Laurie Ailles
    Nature Reviews Urology, 2023, 20 : 96 - 115
  • [29] The lipid metabolomic profile of clear cell renal cell carcinoma (CCRCC)
    George, S.
    Choi, K-S
    Miecznikowski, J.
    Pili, R.
    Kazim, A. L.
    BJU INTERNATIONAL, 2012, 110 : 15 - 16
  • [30] Prognostic biomarkers in patients with clear cell renal cell carcinoma (ccRCC)
    Gandur Quiroga, Maria N.
    Knott, Maria E.
    Pulero, Carla
    Pasik, Leonardo
    Alvarez, Ana M.
    Brzezinski, Mariano
    Malagrino, Hector
    Bal de Kier Joffe, Elisa D.
    Puricelli, Lydia I.
    CANCER RESEARCH, 2012, 72
12345